Altria Has Taken Heat on Vaping. Analyst Says the Stock Is a Buy.

Text size

Altria Uncredited

Altria Group stock has trailed behind the market this year, but even with more awareness of possible health hazards linked to vaping, Argus believes the tobacco giant is still worth buying.

The back story. Altria stock (ticker: MO) is down more than 12% in 2019, while the S&P 500 has risen 16.5%. The company has faced a number of headwinds, including recent vaping-related illnesses that caused investors to question the value of its 35% stake in e-cigarette firm Juul Labs.